» Articles » PMID: 11090131

Role of LXRs in Control of Lipogenesis

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2000 Nov 23
PMID 11090131
Citations 553
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metabolism. The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR. Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species. Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.

Citing Articles

Bioactive lipid signaling and lipidomics in macrophage polarization: Impact on inflammation and immune regulation.

Rodriguez J, Casas J, Balboa M, Balsinde J Front Immunol. 2025; 16:1550500.

PMID: 40028333 PMC: 11867965. DOI: 10.3389/fimmu.2025.1550500.


Role of Protein Regulators of Cholesterol Homeostasis in Immune Modulation and Cancer Pathophysiology.

Wang Y, Bendre S, Krauklis S, Steelman A, Nelson E Endocrinology. 2025; 166(4).

PMID: 39951497 PMC: 11878532. DOI: 10.1210/endocr/bqaf031.


Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome.

Cozzolino K, Sanford L, Hunter S, Molison K, Erickson B, Courvan M Elife. 2025; 13.

PMID: 39928031 PMC: 11810109. DOI: 10.7554/eLife.100197.


Lipid metabolism in myeloid cell function and chronic inflammatory diseases.

Ito A, Suganami T Front Immunol. 2025; 15:1495853.

PMID: 39911578 PMC: 11794072. DOI: 10.3389/fimmu.2024.1495853.


A mutation in LXRα uncovers a role for cholesterol sensing in limiting metabolic dysfunction-associated steatohepatitis.

Clark A, Russo-Savage L, Ashton L, Haghshenas N, Amselle N, Schulman I Nat Commun. 2025; 16(1):1102.

PMID: 39875396 PMC: 11775210. DOI: 10.1038/s41467-025-56565-8.


References
1.
Willy P, Umesono K, Ong E, Evans R, HEYMAN R, Mangelsdorf D . LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995; 9(9):1033-45. DOI: 10.1101/gad.9.9.1033. View

2.
Rubins H, Robins S, Collins D, Fye C, Anderson J, Elam M . Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999; 341(6):410-8. DOI: 10.1056/NEJM199908053410604. View

3.
Lopez J, Bennett M, Sanchez H, Rosenfeld J, Osborne T . Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci U S A. 1996; 93(3):1049-53. PMC: 40028. DOI: 10.1073/pnas.93.3.1049. View

4.
Benlian P, DE GENNES J, Foubert L, Zhang H, Gagne S, Hayden M . Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996; 335(12):848-54. DOI: 10.1056/NEJM199609193351203. View

5.
Shimano H, Horton J, Hammer R, Shimomura I, Brown M, Goldstein J . Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 1996; 98(7):1575-84. PMC: 507590. DOI: 10.1172/JCI118951. View